Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Cell-cell adhesion-regulating proteins as antitumor treatment

July 19, 1996

Potent selective protein farnesyltransferase inhibitor from Pierre Fabre

July 19, 1996

Clarion's CPR-1007 shows antitumor, antipsoriatic and antiinflammatory activity

July 19, 1996

Alfacell's Onconase warrants combination therapy studies

July 19, 1996

More anthracycline antibiotics from Mercian

July 19, 1996

SS-288A/SS-288B: mew anthracycline antibiotics from Mercian

July 19, 1996

ACIC research reveals antineoplastic agents

July 19, 1996

Antitumor platinum complexes disclosed by Boehringer Mannheim

July 19, 1996

IB-367: IntraBiotic's first drug candidate

July 12, 1996

Multidrug resistance modifiers from Vertex

July 12, 1996

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 13, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...